Till startsida
To content Read more about how we use cookies on gu.se

Multiple Sclerosis (MS)

Multiple sclerosis (MS) is an inflammatory and degenerative chronic disease of the central nervous system. After traumatic injury, it is the most common cause of neurological disability in young adults. In Sweden, about 20,000 people live with MS and annually there is about 1000 new cases. For over 20 years, several effective treatments with immunomodulatory or immunosuppressive effects have been developed.

Our research has focused on finding biomarkers in cerebrospinal fluid and blood that measure inflammation and degeneration. Current prospective studies also measure neurodegeneration with optical coherence tomography that measures the thickness of the retinal nerve fiber layer in the eye and with automated measurement of the brain volume, using special sequences of magnetic resonance imaging. The goal is to find better diagnostic and prognostic methods as well as better clinically useful methods for evaluating treatment effects at MS.

Principal Investigators

Photo - Jan Lycke

Jan Lycke


E-mail: jan.lycke@neuro.gu.se
Phone: +46 31-342 90 47
Mobile phone: +46 73 310 91 49


Photo - Oluf Andersen

Oluf Andersen

Professor Emeritus

E-mail: oluf.andersen@neuro.gu.se
Telefon: +46 31-342 90 66
Mobile phone: +46 70 722 51 16

Page Manager: Katinka Almrén|Last update: 1/17/2019

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?